Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netakimab + UDCA in Primary Biliary Cholangitis
NCT03476993Phase 2Terminated
- Sponsor
- BIOCAD
- Start
- Apr 2018
- Primary completion
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of netakimab in primary biliary cholangitis (PBC), sponsored by BIOCAD. Started Apr 2018; status: terminated.
02
Drugs
netakimab
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT03476993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03476993.